(Q45053784)

9 December 2017

Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model (English)

1 reference

9 December 2017

1 reference

1 reference

0 references

1 reference

2

1 reference

9 December 2017

Deuffic-Burban S

1

1 reference

PubMed ID

11876793

9 December 2017

Valleron AJ

series ordinal

3

1 reference

9 December 2017

1 March 2002

1 reference

Journal of Viral Hepatitis

9 December 2017

1 reference

9 December 2017

9

1 reference

9 December 2017

2

1 reference

9 December 2017

114-122

1 reference

Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.

9 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00340.X

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00340.X

Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00340.X

Timing of human immunodeficiency virus type 1 (HIV-1) transmission from mother to child: bayesian estimation using a mixture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00340.X

Modeling the hepatitis C virus epidemic in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00340.X

Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00340.X

Risk of hepatitis C virus transmission to surgeons and nurses from infected patients: model-based estimates in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00340.X

Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00340.X

10.1046/J.1365-2893.2002.00340.X

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference

PubMed ID

11876793